(PINK) Simplify Exchange Traded - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US82889N7729 • Health
PINK: Medicines, Medical, Healthcare, Biotech, Pharmaceuticals, Diagnostics
Under normal circumstances, the fund will invest at least 80% of its assets (plus any borrowings for investment purposes) in securities of U.S. health care companies. The fund adviser defines health care companies as companies included in the Global Industry Classification Standard health care sector. The fund will typically invest in 50 ' 100 health care companies. The adviser generally seeks investments in companies that are developing new and effective medicines, as well as companies whose business models reduce costs or improve quality in health care systems.
Additional Sources for PINK ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PINK ETF Overview
| Market Cap in USD | 144m |
| Category | Health |
| TER | 0.50% |
| IPO / Inception | 2021-10-07 |
PINK ETF Ratings
| Growth 5y | 43.5% |
| Fundamental | - |
| Dividend | 37.8% |
| Rel. Strength Industry | -73.3 |
| Analysts | - |
| Fair Price Momentum | 27.15 USD |
| Fair Price DCF | - |
PINK Dividends
| Dividend Yield 12m | 0.31% |
| Yield on Cost 5y | 0.38% |
| Annual Growth 5y | 67.30% |
| Payout Consistency | 66.9% |
PINK Growth Ratios
| Growth Correlation 3m | -81.7% |
| Growth Correlation 12m | 55.2% |
| Growth Correlation 5y | 67.4% |
| CAGR 5y | 6.81% |
| CAGR/Mean DD 5y | 1.08 |
| Sharpe Ratio 12m | 0.26 |
| Alpha | -14.00 |
| Beta | 0.76 |
| Volatility | 19.62% |
| Current Volume | 19k |
| Average Volume 20d | 39.8k |
What is the price of PINK stocks?
As of January 23, 2025, the stock is trading at USD 30.41 with a total of 19,000 shares traded.
Over the past week, the price has changed by +1.56%, over one month by +0.99%, over three months by -5.67% and over the past year by +7.21%.
As of January 23, 2025, the stock is trading at USD 30.41 with a total of 19,000 shares traded.
Over the past week, the price has changed by +1.56%, over one month by +0.99%, over three months by -5.67% and over the past year by +7.21%.
Is Simplify Exchange Traded a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Simplify Exchange Traded (NYSE ARCA:PINK) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.46 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PINK as of January 2025 is 27.15. This means that PINK is currently overvalued and has a potential downside of -10.72%.
Partly, yes. Based on ValueRay Analyses, Simplify Exchange Traded (NYSE ARCA:PINK) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.46 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PINK as of January 2025 is 27.15. This means that PINK is currently overvalued and has a potential downside of -10.72%.
Is PINK a buy, sell or hold?
Simplify Exchange Traded has no consensus analysts rating.
Simplify Exchange Traded has no consensus analysts rating.
What are the forecast for PINK stock price target?
According to ValueRays Forecast Model, PINK Simplify Exchange Traded will be worth about 30 in January 2026. The stock is currently trading at 30.41. This means that the stock has a potential downside of -1.48%.
According to ValueRays Forecast Model, PINK Simplify Exchange Traded will be worth about 30 in January 2026. The stock is currently trading at 30.41. This means that the stock has a potential downside of -1.48%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 30 | -1.5% |